BEIJING – After selecting Shanghai as the location for its high-profile executive board meeting last July, Merck KGAA is now facing a different China and a market with a slowing growth rate.
INTERVIEW: Merck Serono CEO On Growing In A Slowing China
Despite a slowing Chinese economy and a plethora of layoffs announced by multinational drug makers, Merck KGaA sees growth opportunities via localization and partnering in China. But MNCs have to fully grasp the volatility embedded in the emerging markets, says Merck Serono CEO Belén Garijo.